AP-267

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAP-267
Drug Alias Nameserotonin modulator (AcurePharma)AP-267
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2c (5-HT2c) receptor modulators
TargetsSerotonin 2c (5-HT2c) receptor
Therapy Area/IndicationsStress Disorders, Traumatic, AcuteOpioid-Related DisordersAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAcure Pharma AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAcure Pharma AB
Active IndicationsN/A
Inactive IndicationsStress Disorders, Traumatic, AcuteOpioid-Related DisordersAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A